Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Zhengzhou UniversityActive in the last 2 years

Shishi Qiao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8979-1985; OpenAlex author ID A5101449862. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 4

  1. Identifying drug candidates for pancreatic ductal adenocarcinoma based on integrative multiomics analysis. Co-author DOI 10.21037/jgo-23-985↗
  2. SOX21-AS1 activated by STAT6 promotes pancreatic cancer progression via up-regulation of SOX21. Co-author DOI 10.1186/s12967-022-03521-5↗
  3. A laparoscopic pancreaticoduodenectomy for pancreatic adenocarcinoma in a patient with situs inversus totalis. Last author DOI 10.1093/jscr/rjab316↗
  4. Role of exosomes in pancreatic cancer. First author DOI 10.3892/ol.2021.12559↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Huahu Guo · 1 shared paper, 2024 · strength 0.21
  2. Zhiqiang Gao · 1 shared paper, 2024 · strength 0.21
  3. Huayu Yang · 1 shared paper, 2024 · strength 0.21
  4. Penglei Ge · 1 shared paper, 2024 · strength 0.21
  5. Yang Wu · 1 shared paper, 2024 · strength 0.21
  6. Dandan Yu · 1 shared paper, 2022 · strength 0.17
  7. Guanghui Zhu · 1 shared paper, 2022 · strength 0.17
  8. Maher Al Hussan · 1 shared paper, 2021 · strength 0.16
  9. Shuai Huang · 1 shared paper, 2021 · strength 0.16
  10. Hao Liu · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.